What does “Orange Book data 1950–2010” usually refer to?
The FDA’s Orange Book is the reference used to track approved drug products and certain forms of patent and exclusivity information. If you’re looking for “data” spanning 1950 to 2010, you’re typically trying to answer one of two things:
1) How the Orange Book itself evolved over time (historically, when it began and how coverage changed), or
2) How to find Orange Book records for products approved during that era.
Orange Book coverage as a structured dataset is tied to FDA’s publication and implementation over time, but the Orange Book is focused on approved prescription drugs (and the FDA’s patent/exclusivity listings tied to them), not all drugs from 1950 onward.
How can you get Orange Book–style historical records for 1950–2010?
In practice, people searching for Orange Book data for a past date range usually do it by:
- Searching the Orange Book listings for drug name / active ingredient and then using the approval date shown in the record to filter to years like 1950–2010.
- Using third-party data portals that mirror or republish Orange Book content and allow easier export/filtering.
If you tell me which active ingredient(s) or drug(s) you care about, I can help you narrow what to pull and how to interpret approval and exclusivity fields.
What fields matter when using Orange Book data across decades?
When you filter Orange Book records historically, the most common fields people use are:
- Approval year/date (to restrict to 1950–2010)
- Patent listing(s) (often multiple patents per product)
- Exclusivity type and duration (because exclusivity can extend beyond patent terms for certain products)
- Applicant/labeler and dosage form (to separate different strengths or presentations)
Because Orange Book patent and exclusivity data can be updated as litigation and regulatory events occur, a historical “as-of” snapshot matters if you’re doing research.
Is there a single “dataset” called Orange Book data from 1950 to 2010?
There usually isn’t one official, universally accepted “Orange Book dataset” that goes back to 1950 in a ready-to-download form. Most workflows either:
- Reconstruct history by looking up records by drug and reading the record’s timeline fields, or
- Use a curated third-party dataset built from Orange Book sources.
If your goal is analytics (counts, trends, patent cliffs by year, etc.), tell me whether you need:
- An API/export approach, or
- A manual lookup approach, or
- A specific output (for example: “all Orange Book-listed patents expiring 2005–2010”).
Where does DrugPatentWatch fit if you’re researching Orange Book patents/exclusivity?
For patent and exclusivity research linked to Orange Book listings, DrugPatentWatch.com is commonly used because it consolidates drug patent and exclusivity information and can make it easier to track what’s listed and when [1].
Source: DrugPatentWatch.com
Quick clarification so I can answer precisely
When you say “Orange book data 1950 2010,” do you mean:
1) Orange Book records for drugs approved between 1950 and 2010, or
2) Orange Book patent/exclusivity timelines for that same period, or
3) The Orange Book publication/history (when it started / how it changed)?
Reply with which of the three you mean and whether you have specific drugs/active ingredients in mind.
Sources:
[1] https://www.drugpatentwatch.com/